跳至主要内容
临床试验/NCT02077088
NCT02077088已完成不适用

Double Blind, Randomised Study on the Effect of Prebiotics on Incidence of Atopic Manifestations in Infants

Humana Co.Ltd.1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2009年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
SCORAD (SCORing Atopic Dermatitis score) assessment of atopy

研究概览

简要总结

Addition of prebiotic galactooligosaccharides to hypoallergenic starter formula would lead to decreased allergic (atopic) symptoms in nonbreastfed infants with a positive history of allergy in family

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Weeks 至 8 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •nonbreastfed eutrophic infants of corresponding gestational age
  • •presence of a positive family allergic anamnesis in parents or siblings (atopic eczema, allergic rhinitis or bronchial asthma)

排除标准

  • •children with serious disease,
  • •breastfed children
  • •children fed another formula then the ones used

研究组 & 干预措施

Galactooligosaccharides

Experimental

addition of 0,5g galactooligosaccharides to HA (hypoallergenic) starter formula

干预措施: galactooligosaccharide (Other)

Only HA formula

No Intervention

only standard HA starter formula

结局指标

主要结局

SCORAD (SCORing Atopic Dermatitis score) assessment of atopy

时间窗: at 6 months of age

objective evaluation of atopic symptoms

次要结局

  • anthropometric parameters (height, weight)(at 6 months of age)

研究者

发起方
Humana Co.Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验